This may in turn suppress PTH in the fetus and may explain why newborns of mothers with CYP24A1 mutations are at risk of both, hypercalcemia due to transfer of calcium from the mother during pregnancy and of hypocalcemia due to suppression of PTH. The gene discussed is CYP24A1; the disease is Hypocalcemia.